Filter

41 - 50 of 515 Results

  • Views and Experiences Related to Women’s Health in Texas

    Report

    Using data from the Kaiser Family Foundation/Episcopal Health Foundation 2018 Texas Health Policy Survey, this brief explores how Texas women and men rank legislative priorities in the state, including health care issues of importance to women such as reducing maternal mortality and increasing access to reproductive services. It also compares gender differences in the share of Texas residents who report problems paying medical bills and postponing health care because of the cost.

  • Kaiser Health Tracking Poll: March 2016

    Feature

    The March Kaiser Health Tracking Poll finds that health care is one of many issues that will be important to voters in the Presidential election, trailing concerns about the economy and jobs but leading concerns about immigration. Health care ranks higher for Democratic voters than for Republican and independent voters and is a higher priority for women than for men. Health care costs remain on the forefront of the minds of both the uninsured and…

  • National Survey on Public Perceptions about Contraception

    Poll Finding

    A national random-sample telephone survey conducted between January 19-21, 1996 on Americans perceptions of the risks and benefits associated with oral contraceptives, or The Pill. The survey finds that many American men and women have at least some concerns about the safety of oral contraceptives. These findings were presented at a briefing in New York on January 31, 1996, co-sponsored by Kaiser Family Foundation, the National Press Foundation and The Alan Guttmacher Institute. TOPLINE Download…

  • National Survey Of Obstetricians/Gynecologists On Contraception And Unplanned Pregnancy: Attitudes And Practices With Regard To Abortion

    Poll Finding

    National Survey Of Obstetricians/Gynecologists On Contraception And Unplanned Pregnancy: Attitudes And Practices With Regard To Abortion The survey findings show only one third of obstetricians/gynecologists practicing today perform abortions. Younger doctors, doctors in multi-specialty group practices, and doctors practicing in the South and Midwest are among those least likely to perform abortions. The survey also finds that many of the physicians who do not perform abortions say they would, however, offer Mifepristone, if approved by…

  • Employer Coverage of Travel Costs for Out-of-State Abortion

    Policy Watch

    This Policy Watch gives an overview of employers offering to cover travel expenses for workers who need to go out of state for an abortion in the context of increasing restrictions on abortion around the country. We discuss who is offering these benefits, the implications for workers, and some of the legal and political concerns for employers.

  • Coverage and Use of Fertility Services in the U.S.

    Issue Brief

    This brief examines how access to fertility services, both diagnostic and treatment, varies across the U.S., based on state regulations, insurance type, income level and patient demographics.

  • Issue Brief Explores Consequences of Potential Supreme Court Decisions on the ACA Contraceptive Coverage Requirement

    News Release

    A new Kaiser Family Foundation issue brief explores some of the factors influencing employers’ coverage decisions and possible consequences for employers and workers that could arise from possible Supreme Court decisions in the cases brought by Hobby Lobby and Conestoga Wood Specialties, for-profit corporations challenging the Affordable Care Act’s requirement to cover contraceptive services and supplies in health insurance. Other resources about the Supreme Court case are also available online.

  • KFF Health Tracking Poll: Knowledge and Views of Medication Abortion

    Poll Finding

    This KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.